News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
ASCOQLTY24 abstract submissions are due by May 21!
Photo taken from ASCO/LinkedIn
May 17, 2024, 03:09

ASCOQLTY24 abstract submissions are due by May 21!

ASCO shared a post on LinkedIn:

“ASCOQLTY24 abstract submissions are due by May 21!

Share your science at the primary meeting for innovative, data-driven, interdisciplinary cancer science that will help improve the quality of cancer care.”

Proceed to the video attached to the post.
Source: ASCO/LinkedIn

ASCO ASCOQLTY24 cancer cancer care OncoDaily Oncology
Blog
Jul 4, 2024, 12:20
Aman Chauhan: Rare and aggressive cancer requires funding to develop better treatments
Blog
Jul 4, 2024, 12:15
Angela Lamarca: We MUST validate innovate biomarkers in clinical trials
Blog
Jul 4, 2024, 12:11
CANCaRe Africa’s Wilms Africa Project
Societies
Jul 4, 2024, 12:08
Neeraj Agarwal and Rana McKay highlight key studies in urothelial and renal cell carcinomas
Blog
Jul 4, 2024, 12:07
Jordyn Silverstein: Bladder cancer illness script time
Career
Jul 4, 2024, 12:02
Sarah Cohen-Gogo: I'm starting a new position as Assistant Professor at University of Toronto
Insight
Jul 4, 2024, 11:59
Mina L. Xu: The power of Hi-C genomic analysis in uncovering lymphoma biology
Blog
Jul 4, 2024, 11:51
Emma B. Holliday: Some unsolicited advice for new radoncs
Insight
Jul 4, 2024, 11:44
Piotr Wysocki: 18F-PSMA-PET/CT beats multiparametric MRI in staging high-risk and intermediate-risk prostate cancers
Blog
Jul 4, 2024, 11:35
Peculiarities of Tumor Lysis Syndrome in Cancer Therapeutics - Chibuike Okafor
Dialogues
Jul 4, 2024, 11:33
Blending Science and Compassion: Exclusive Conversation with ASCO President-Elect Eric J. Small
Blog
Jul 4, 2024, 11:21
Florian Lordick: New first-line treatment algorithm for advanced gastric cancer published in ESMO